Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine in treatment-resistant bipolar depression
NCT00947791Phase 4Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Jul 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in bipolar disorder (BD), sponsored by Icahn School of Medicine at Mount Sinai. Started Jul 2009; status: terminated.
02
Drugs
ketamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00947791.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00947791.